| Drug Manufacturing Licences
• Examination and approval of layout plans
• Processing applications for new licences
• Processing applications for renewal of licensces and inspections
• Inspection of units through panel of Experts / FIDs for
grant and renewal of licences.
• Miscellaneous issues related to the licences
• Execution of orders of the Central Licensing Board.
(2) Scrutiny of applications for advertisements and their approvals,
through committee on Advertising.
(3) Processing of requests for inclusion of raw materials in various
SROs
(4) The legislative matters like amendment in the Act and Rules.
(5) Issues and matters related to basic manufacture in the country.
(6) Convening the meetings of the Central Licensing and Registration
Board.
(7) Miscellaneous and general matters not related specifically to
other sections of the DCA, like coordination
with the Provincial Governments on matters concerning Drugs Act.,
1976, coordination with the other
Ministries and Departments on various subject matter related to
drugs.
Quality Control
• To scrutinize the substandard, misbranded,
spurious, adulterated etc test reports of CDL, Karachi
for obtaining complete investigation reports from the Federal Inspector
of Drugs /Assistant Drugs Controllers.
• To process the cases of substandard, misbranded,
spurious, adulterated etc drugs for presentation
to the Central Licensing and Registration Boards.
• To process the cases of prosecution of
the accused under the Drugs Act., 1976 in the Drugs Courts
referred to by the FID/ADCs.
• To convene the meetings of the Expert
Committee of Central Licensing and Registration Board on
quality Control Cases, preparation working papers, agendas, minutes
and presents the recommendations of
the committee to the Boards for final decision. The decisions of
the Board are also conveyed to the
concerned section for implementation.
• To receive and store Board’s portion
of the samples of drugs sent by all FID/ADCs. In case of appeals,
to process the said samples for appellate testing and presentation
of the cases to the Central Licensing
and Registration Board.
• To receive, scrutinize, maintain, compile
and process the monthly progress reports of the Government
Analysts of the Federal and the Provincial Government Analysts.
• To initiate actions on various complaints
regarding quality control received from individuals, various
agencies through FIDs.
• To inform all the Provincial Governments
and Federal Inspector of Drugs for ensuring effective recall
of drugs is received.
Central Research Fund
• Collection of Central
Research Fund
• Reconciliation of Central Research
Fund
• Auditing of Central Research Fund
Development & Litigation
• Preliminary scrutiny of proposals
for funding from Central Research Fund
• Reference to experts for the evaluation
of proposals for funding of Central Research Fund.
• Follow up of the projects approved
from Central Research Fund.
• Preliminary plans for the development
of pharmaceutical sector.
Local Manufacturing
Initiating action for:-
• Preliminary scrutiny of registration
applications
• Preparation of agenda and working
paper form Drug Registration Board
• Communication of decisions of Drug
Registration Board
• Reference to experts for evaluation
and report on new chemical entities.
• Approval of labels and cartons
• Processing of cases for change
of name of the brand name
• Processing of requests for the
transfer of registration from import to local manufacture
• Processing of cases for cases for
the change of inactive ingredients of already registered drugs
• Processing of cases of changes
in master formulae, finders, diluents, colours and flavours.
• Processing of requests for the
additional packing of already registered drugs.
• Preparations of material for reply
to adjournment motions, resolutions and questions in
National
Assembly and Senate.
• Preparations of material for clarifying
the incorrect or biased press reports.
• Defence of appeals preferred by
the firms aggrieved by the decisions of the Drugs
Registration Board.
• Preparation of price comparisons
for registration of Me-Too drugs
• Initiating action for de-registration
of drugs due to adverse drug reaction.
• Preparation of proposals for promoting
rational use of drugs
• Preparation of reports and parawise
comments on Writ petitions.
• Organization of Seminars, Workshops
to promote CGMP, Quality Assurance and Rational Use
of Drugs
• Compilation of list of registered
drugs
• Supply of unbiased information
about drugs to health professionals.
Import
Initiating action for:-
• Preliminary scrutiny of registration
applications
• Registration of Veterinary drugs
both for locally manufactured and import.
• Preparation of agenda and working
paper form Drug Registration Board
• Communication of decisions of Drug
Registration Board
• Reference to experts for evaluation
and report on new chemical entities.
• Approval of labels and cartons
• Processing of cases for change
of name of the brand name
• Processing of cases for cases for
the change of inactive ingredients of already registered drugs
• Processing of cases of changes
in master formulae, finders, diluents, colours and flavours.
• Processing of requests for the
additional packing of already registered drugs.
• Preparations of material for reply
to adjournment motions, resolutions and questions in
National
Assembly and Senate.
• Preparations of material for clarifying
the incorrect or biased press reports.
• Defence of appeals preferred by
the firms aggrieved by the decisions of the Drugs
Registration Board.
• Preparation of price comparisons
for registration of Me-Too drugs
• Preparation of reports and parawise
comments on Writ petitions.
• Compilation of list of registered
drugs for import
• Supply of unbiased information
about drugs to health professionals.
Pakistan National Formulary
• Compilation, Publication
of Pakistan National Formulary.
• Compilation, Publication of Pakistan
Pharmacopoeia
• Supply of Drug Information to Health
Professionals
Adverse Drug Reaction Monitoring
• Compilation and supply of unbiased
information on Poison Control
• Compilation and submission of report
about Adverse Drug Reaction
• Compilation and submission of reports
about Clinical Trials.
Pricing
• Price fixation
• Compilation and supply of data
on prices of registered drugs.
E&M
• Compilation and supply of data
on the prices of raw materials including excipients and packing
materials
|